[1] | CILEK A,CELEBI N,TIRNAKSIZ F,et al.A lecithin-based microemulsion of rh-insulin with aprotinin for oraladministration:Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats[J].Int J Pharm.2005,298(1):176-186 | [2] | LAWRENCE M J,REES G D.Microemulsion-based mediaas novel drug delivery systems[J].Adv Drug Deliv Rev.2000,45(1):89-121 | [3] | PODLOGAR F,GASPERLIN M,TOMSIC M,et al.Structural characterisation of water-Tween40/Imwitor308-isopropyl myristate microemulsions using differentexperimental methods[J].Int J Pharm.2004,276(1/2):115-128 | [4] | KREILGARRD M,PEDERSEN E J,JAROSZEWSKI J W.NMR characterisation and transdermal drug deliverypotential of microemulsion systems[J].J Control Release.2000,69(3):421-433 | [5] | ½��,����ȫ.��������ͼ���о�ҩ������γ�����[J].ҩѧѧ��,2001,36(1):58-62. | [6] | ½��.ҩ���¼������¼���[M].����:��������������,1998. | [7] | LYONS K C,CHARMAN W N,MILLER M,et al.Factors limiting the oral bioavailability of N-acetylglucos-aminyl-N-acetyl-muramyl dipeptide(GMDP)andenhancement of absorption in rats by delivery in a water-in-oil microemulsion[J].Int J Pharm.2000,199(1):17-26 | [8] | WARISNOICHAROEN W,LANSLEY A B,LAWRENCEM.Nonionic oil-in-water microemulsions:The effect of oiltype on phase behavior[J].Int J Pharm.2000,198(1):7-16 | [9] | SCHECHTER R S.Microemulsion and Related Systems[M].New York:Marcel Dekker,1998. | [10] | ����,����,������,��.����ͪ����Ʊ�����������[J].�й���ҩ��־,2003,28(11):1 081-1 085. | [11] | ��ѩ��,��ѩ��,������,��.������A��ڷ�Һ���Ʊ����ȶ��Ե��о�[J].�й��ִ�Ӧ��ҩѧ,2004,21(1):40-43. | [12] | �Ž���,����ѫ,��ԭ,��.�����������Ƽ�������[J].�й�ҽԺҩѧ��־,2003,23(1):9-14. |
|